Status:
COMPLETED
Frequency of Tuberculosis in Psoriasis Patients
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Psoriasis Vulgaris
Tuberculosis
Eligibility:
All Genders
18-100 years
Brief Summary
Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.
Detailed Description
Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center. TNF inhibitor therapy may increase the risk for tubercul...
Eligibility Criteria
Inclusion
- psoriasis patients receiving TNF inhibitor therapy
Exclusion
- patients without TNF inhibitor therapy
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
719 Patients enrolled
Trial Details
Trial ID
NCT06563635
Start Date
May 1 2023
End Date
July 31 2023
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University Hospital
Istanbul, Turkey (Türkiye)